Title : Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma.

Pub. Date : 2021 Oct 1

PMID : 33480649






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The BCL-2 inhibitor venetoclax combined with hypomethylating agents like decitabine, has shown favorable responses in elderly patients with acute myeloid leukemia. Decitabine BCL2 apoptosis regulator Homo sapiens